Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||-2.44%||68.93||1.0%||$497.91m|
|REGN||Regeneron Pharmaceuticals, Inc.||-2.73%||636.53||2.7%||$490.45m|
|VRTX||Vertex Pharmaceuticals, Inc.||-1.67%||186.94||1.9%||$375.32m|
|SNSS||Sunesis Pharmaceuticals, Inc.||0.88%||4.61||0.7%||$322.26m|
|EXAS||EXACT Sciences Corp.||-1.39%||85.37||18.0%||$167.68m|
|BMRN||BioMarin Pharmaceutical, Inc.||-1.27%||86.29||4.2%||$144.64m|
ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of immuno-oncology platforms that leverage cell- and gene-based therapies to treat patients with cancer. Its pipeline includes Sleeping Beauty TCR-T Targeting neoantigens; Ad-RTS-hlL-12 + veledimex; and Sleeping Beauty CAR-T. The company was founded on September 9, 2003 and is headquartered in Boston, MA.